Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;54(10):2733-2744.
doi: 10.1007/s11255-022-03165-w. Epub 2022 Apr 11.

Artificial intelligence assessment for early detection and prediction of renal impairment using electrocardiography

Affiliations

Artificial intelligence assessment for early detection and prediction of renal impairment using electrocardiography

Joon-Myoung Kwon et al. Int Urol Nephrol. 2022 Oct.

Abstract

Purpose: Although renal failure is a major healthcare burden globally and the cornerstone for preventing its irreversible progression is an early diagnosis, an adequate and noninvasive tool to screen renal impairment (RI) reliably and economically does not exist. We developed an interpretable deep learning model (DLM) using electrocardiography (ECG) and validated its performance.

Methods: This retrospective cohort study included two hospitals. We included 115,361 patients who had at least one ECG taken with an estimated glomerular filtration rate measurement within 30 min of the index ECG. A DLM was developed using 96,549 ECGs of 55,222 patients. The internal validation included 22,949 ECGs of 22,949 patients. Furthermore, we conducted an external validation with 37,190 ECGs of 37,190 patients from another hospital. The endpoint was to detect a moderate to severe RI (estimated glomerular filtration rate < 45 ml/min/1.73m2).

Results: The area under the receiver operating characteristic curve (AUC) of a DLM using a 12-lead ECG for detecting RI during the internal and external validation was 0.858 (95% confidence interval 0.851-0.866) and 0.906 (0.900-0.912), respectively. In the initial evaluation of 25,536 individuals without RI patients whose DLM was defined as having a higher risk had a significantly higher chance of developing RI than those in the low-risk group (17.2% vs. 2.4%, p < 0.001). The sensitivity map indicated that the DLM focused on the QRS complex and T-wave for detecting RI.

Conclusion: The DLM demonstrated high performance for RI detection and prediction using 12-, 6-, single-lead ECGs.

Keywords: Artificial intelligence; Deep learning; Electrocardiography; Renal insufficiency.

PubMed Disclaimer

Conflict of interest statement

KHK, SYL, and BHO declare that they have no competing interests. JK and JP are co-founder and YYJ, MSJ, YJL, YHC, and JHS are researchers of Medical AI Co., a medical artificial intelligence company. JK and JHB are researchers of Body friend Co. There are no products in development or marketed products to declare. This does not alter our adherence to Journal.

Figures

Fig. 1
Fig. 1
Architecture of deep learning based model for detecting renal impairment. Legend: 1D denotes 1-dimension and Conv convolution neural network
Fig. 2
Fig. 2
Performances of deep learning-based model for detecting renal impairment. Legend: †The alternative hypothesis for this p value was that there was a difference of AUC between the 12-lead ECG model and others. AUC denotes area under the receiver operating characteristic curve, ECG electrocardiography, EGFR estimated glomerular filtration rate, NPV negative predictive value, PPV positive predictive value, SEN sensitivity, and SPE specificity
Fig. 3
Fig. 3
Sensitivity map of deep learning based model for detecting renal impairment
Fig. 4
Fig. 4
Cumulative risk of patients with no initial renal impairment developing renal impairment

References

    1. Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med. 2010;363:1833–1845. doi: 10.1056/NEJMra0902710. - DOI - PubMed
    1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao M, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–1982. doi: 10.1016/S0140-6736(14)61601-9. - DOI - PubMed
    1. Ruggenenti P, Cravedi P, Remuzzi G. Mechanisms and treatment of CKD. J Am Soc Nephrol. 2012;23:1917–1928. doi: 10.1681/ASN.2012040390. - DOI - PubMed
    1. Trivedi HS, Pang MMH, Campbell A, Saab P. Slowing the progression of chronic renal failure: economic benefits and patients’ perspectives. Am J Kidney Dis. 2002;39:721–813. doi: 10.1053/ajkd.2002.31990. - DOI - PubMed
    1. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389:1238–1252. doi: 10.1016/S0140-6736(16)32064-5. - DOI - PubMed

LinkOut - more resources